Clinical Utilization of Point-of-Care Blood L-Lactate
Concentrations in Naturally Occurring Respiratory Disease in Feedlot
Cattle
Mohamed
Zeineldin1, 2
*, Mohamed Ghanem2,
Yassein Abd El-Raof2
and Hossam Elattar2
1Integrated Food Animal Management Systems, Department of
Veterinary Clinical Medicine, College of Veterinary Medicine,
University of Illinois at
Urbana-Champaign; 2Department of Animal Medicine, College
of Veterinary Medicine, Benha University, Egypt *Corresponding author:zeineldn@illinois.edu
Abstract
Assessment of blood L-lactate concentration (LAC)
as point-of-care (POC) biomarkers is turning into a typical procedure for
different diagnostic purposes in the food animal industry. The purpose of our
study was to figure out whether blood LAC measured by a
hand held lactate analyzer with different variables could be
utilized to anticipate the event of bovine respiratory disease (BRD) in feedlot
cattle. Moreover, assess the blood LAC stability over different time point in
clinically healthy feedlot cattle. Blood
sample was collected at entry during processing (n=104) and at initial diagnosis
of BRD (n=24). In addition, clinically healthy
pen matched controls calves (n=24) were sampled at the same time of
pulling diseased calves for determination of blood LAC using a handheld portable
lactate analyzer. In a separate study, selected clinically healthy calves (n=9)
were sampled and blood LAC stability at the different
time point (0, 30, 60, 90 and 120 minute) was assessed. Logistic regression
model revealed blood LAC during initial processing was significantly associated
with odds of becoming a BRD case in calves revealing lung score 2. Moreover,
blood LAC was significantly different
(P=0.02) between clinically healthy and those calves that developed BRD and was
significantly correlated (P>0.01) within the different time points.
Our results demonstrated that analyzing
blood LAC at initial diagnosis of BRD together with
other clinical variable might help in the
treatment decision. Therefore, further investigation should be designed to correlate blood LAC measurements for prediction of
BRD clinical outcomes.